Resveratrol is a polyphenol that activates SIRT1, a sirtuin that plays a crucial role in promoting mitochondrial biogenesis. This activation potentially leads to an increased demand for mitochondrial ribosomal proteins like MRP-L41, as new mitochondria require a full complement of proteins for function. Similarly, pioglitazone, a PPAR-gamma agonist, and nicotinamide mononucleotide (NMN), a NAD+ precursor, also support the process of mitochondrial biogenesis, potentially ramping up the production of mitochondrial components, including MRP-L41. Contrastingly, certain compounds disrupt mitochondrial function, eliciting a stress response that can indirectly affect MRP-L41 levels. Oligomycin A, for example, inhibits ATP synthase, resulting in mitochondrial stress that might upregulate MRP-L41 as part of a broader cellular attempt to compensate for impaired energy production. FCCP, another mitochondrial disruptor, decouples oxidative phosphorylation, which could lead to a similar compensatory increase in mitochondrial proteins. Substances like sodium azide, rotenone, and antimycin A target different enzymes within the electron transport chain, potentially triggering a response that upregulates protective proteins, including MRP-L41, to preserve mitochondrial integrity and function.
Rapamycin, an inhibitor of the mTOR pathway, induces autophagy – a cellular degradation process that can lead to the turnover of mitochondrial components. This process may necessitate the synthesis of new mitochondrial proteins, including MRP-L41, to replace those that are degraded. 1,1-Dimethylbiguanide, Hydrochloride, widely known for its role in diabetes management, activates AMPK, leading to increased mitochondrial biogenesis and possibly a higher expression level of MRP-L41 as cells seek to meet energy demands. Chloramphenicol, traditionally used as an antibiotic, can affect the mitochondrial ribosome due to its similarity to bacterial ribosomes. This off-target effect may influence the stability and expression of mitochondrial ribosomal proteins, including MRP-L41.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates SIRT1, which may enhance mitochondrial biogenesis, potentially increasing the demand for mitochondrial ribosomal proteins like MRP-L41. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Inhibits ATP synthase, causing mitochondrial stress which can upregulate mitochondrial proteins including MRP-L41 for compensatory effects. | ||||||
5-Aminolevulinic Acid Hydrochloride Salt | 5451-09-2 | sc-262399 sc-262399A sc-262399B sc-262399C | 1 g 5 g 25 g 100 g | $41.00 $110.00 $320.00 $1400.00 | 2 | |
Precursor in heme synthesis; heme can modulate mitochondrial function and thereby influence the expression of mitochondrial proteins such as MRP-L41. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $94.00 $355.00 | 46 | |
Uncouples oxidative phosphorylation, which may trigger a compensatory increase in mitochondrial proteins, including MRP-L41. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibitor of mTOR that can induce autophagy and potentially influence the turnover and synthesis of mitochondrial proteins, including MRP-L41. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
PPAR-gamma agonist which can enhance mitochondrial biogenesis, possibly upregulating the expression of mitochondrial ribosomal proteins like MRP-L41. | ||||||
Sodium azide | 26628-22-8 | sc-208393 sc-208393B sc-208393C sc-208393D sc-208393A | 25 g 250 g 1 kg 2.5 kg 100 g | $43.00 $155.00 $393.00 $862.00 $90.00 | 8 | |
Inhibits cytochrome c oxidase in the ETC, potentially increasing the expression of mitochondrial proteins like MRP-L41 in response to impaired mitochondrial function. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Inhibits mitochondrial complex I, which may lead to reactive oxygen species production and upregulation of mitochondrial protective proteins, including MRP-L41. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $55.00 $63.00 $1675.00 $4692.00 | 51 | |
Inhibits mitochondrial complex III, possibly triggering a cellular response that upregulates mitochondrial proteins such as MRP-L41. | ||||||
β-Nicotinamide mononucleotide | 1094-61-7 | sc-212376 sc-212376A sc-212376B sc-212376C sc-212376D | 25 mg 100 mg 1 g 2 g 5 g | $110.00 $150.00 $220.00 $300.00 $600.00 | 4 | |
NAD+ precursor which can enhance mitochondrial function and possibly upregulate mitochondrial proteins including MRP-L41. | ||||||